Search

everythinglearnresearchcommunity

for

Search:↓

The document concludes that it's important to understand the placebo effect when evaluating the effectiveness of treatments in medical trials.

The study found three different timing patterns of symptoms in women with premenstrual dysphoric disorder.

Nanoemulsions improve stability and delivery of active ingredients in cosmetics for skin and hair care.

Smart hydrogel dressings could improve diabetic wound healing by adjusting to wound conditions and controlling drug release.

Colostrum-derived exosomes can promote hair growth and may be a promising treatment for hair loss.

Apremilast shows promise for several skin conditions but needs more research.

5% minoxidil works better for hair growth than 1% minoxidil.

The meeting highlighted the genetic basis of female pattern hair loss and various skin health insights.

Extracts from Tridax procumbens L. have strong anti-inflammatory and antioxidant effects and block inflammation-causing enzymes.

Personalized medicine in dermatology uses molecular biomarkers to improve diagnosis and treatment but needs further advancements for practical use.

New targeted immunotherapies are improving treatment for inflammatory skin diseases.

Methylated flavonoids may effectively reduce depression and inflammation caused by finasteride.

Type-2 immunity may influence skin diseases and could be targeted for treatment.

Fulvestrant is a well-tolerated new treatment for advanced breast cancer that may delay chemotherapy.

Experts agree on how to manage sugar levels and skin reactions in patients taking the cancer drug alpelisib.

Finasteride effectively treats enlarged prostate and male baldness, improves symptoms of hirsutism in women, but doesn't work for acne, and may delay prostate cancer progression with few side effects.

Finasteride increases hair count and improves hair growth with low risk of side effects.

Use antiandrogens and other treatments for hair loss.

Hidradenitis suppurativa is a chronic skin condition more common in women, linked to genetics and lifestyle factors, and associated with various other health issues.

Exosome treatment for hair growth is promising but not FDA-approved and needs more research on safety and how it works.

Using iontophoresis on minoxidil sulphate-loaded chitosan nanoparticles increases drug release but reduces its targeting to hair follicles.

Telogen Effluvium is a common hair loss condition that can be short-term or long-lasting and is often caused by stress, illness, or nutritional issues.

Platelet-Rich Plasma therapy helps increase hair density and regrowth for some types of hair loss.

Finasteride and minoxidil are effective for hair regrowth, while treatments for alopecia areata have varying success and continuous treatment is necessary.

Psychotropic medications can cause skin reactions, including severe conditions like SJS and TEN, and it's important for psychiatrists to recognize and manage these side effects.

As people get older, they have less active hair growth, but women have thicker hair than men and respond better to hair loss treatments.

The combination of gemcitabine and vinorelbine is effective and safe for treating elderly patients with advanced breast cancer previously treated with anthracyclines and taxanes.

Machine learning can predict symptoms and quality of life in chronic skin disease patients using smartphone app data, and shows that app use varies with patient characteristics.

Teriflunomide effectively reduces relapses and disability in MS and has a manageable safety profile.

Testosterone therapy for postmenopausal women appears safe and may protect against heart disease, but requires constant monitoring and more research for long-term effects.